US agrees to purchase 100M doses of Pfizer COVID-19 vaccine candidate for $1.95B

The U.S. will pay drug company Pfizer $1.95 billion to produce and deliver 100 million doses of the company's COVID-19 vaccine candidate should the drug prove effective in human tr…